Market Overview
The Global Assisted Reproductive Technology Market is expected to reach a value of USD 28.7 billion in 2023, and it is further anticipated to reach a market value of USD 49.0 billion by 2032 at a CAGR of 6.1%.
Assisted Reproductive Technology (ART) includes different procedures, like ICSI (intracytoplasmic sperm injection), IVF (in vitro fertilization), cryopreservation of embryos or gametes, fertility medications, & more. ART includes employing medical methods to address infertility, defined by the World Health Organization as the inability to conceive naturally after a year without contraception. Both men & women can experience infertility, and when these techniques are utilized to address infertility, they're termed fertility treatments. ART mainly serves to address infertility & reproductive endocrinology issues, with surrogacy arrangements often influenced by these methods.
Recent developments in Assisted Reproductive Technology (ART) market show its explosive growth, especially with regards to IVF services expansion. Australia recently launched an investment initiative of millions that will make fertility treatments more accessible, including subsidies for ART procedures; this effort seeks to address rising infertility issues while simultaneously increasing fertility rates overall.
Growing demand for assisted reproductive technology (ART) services is being driven by social shifts, with an increase in single parents, same-sex couples and individuals choosing ART as an avenue to build families. This trend demonstrates a cultural acceptance of diverse family structures which is driving adoption of these services worldwide - Japan and India being prime examples where demand has skyrocketed.
Technological innovations are expanding opportunities in the ART market. Developments such as non-invasive genetic testing and embryo screening are improving success rates and patient outcomes, while private equity investments like Baring Private Equity's acquisition of Indira IVF by expanding access to treatment in developing regions further propelled market expansion.
Global IVF market witnessed more than two million cycles performed annually, resulting in approximately 300,000. Over 69,000 children were born via IVF in Japan alone during 2021 while India saw its fertility clinic count grow from 150 in 2011 to over 2,500 by 2023.
This growth can be attributed primarily to increasing awareness and acceptance of assisted reproductive technologies.
Australia recently made an investment of USD 42.3 million into artificial reproductive technology (ART), in response to an estimated 1 in 6 Australians facing infertility. Demand for services such as embryo freezing and genetic screening continues to increase with increasing success rates for ART treatments in Australia; similarly 2.3% of births take place via ART treatment here in the U.S.
Market Dynamic
The growth of the Assisted Reproductive Technology market in the coming years is highly influenced by a growing number of single parents & rise in awareness regarding same-sex marriages & ART options. Further, in 2022, 32 countries legally recognized same-sex marriages, with more nations moving toward similar recognition, as indicated by the Human Rights Campaign (HRC) Foundation. The growth in the prevalence of same-sex marriages is anticipated to drive a notable demand increase for ART techniques, fueling market growth.
However, certain factors could challenge the ART market's progress in the forecasted period, which includes growing medical procedure costs, ethical concerns, the risk of prematurity associated with ART, & a relatively lower success rate. These challenges may create obstacles to the market's growth despite the driving factors, raising concerns about its growth potential.
Research Scope and Analysis
By Type
While considering the types of assisted reproductive technology market segments into
In Vitro Fertilization (IVF), artificial insemination & others. IVF will take the lead in global revenue in 2023, which includes frozen donor, fresh donor, fresh non-donor, & frozen non-donor procedures. where the frozen non-donor IVF procedure stands out due to its advantages over other IVF methods, as it is preferred when a woman has healthy eggs but requires ART due to male infertility or fallopian tube issues, this approach's popularity is rising compared to other IVF methods.
Also,
artificial insemination is anticipated to have high growth during the forecast period, which includes categories like intracervical, intrauterine, intravaginal, & intratubal insemination. Mainly employed for minor fertility issues, it's often chosen by same-sex couples or single women. Success rates differ by age, with higher chances for young women, as reported by the Human Fertilization and Embryology Authority (HFEA). In addition, the majority of women undergoing intrauterine insemination achieve pregnancy within their first 6 cycles.
By End User
The global assisted reproductive technology market is categorized by end-users into
fertility clinics, hospitals, and others. The fertility clinics segment takes the lead in 2023, contributing the largest share of the industry's total revenue, which is anticipated to maintain its dominant position throughout the forecast period, growing at a high rate. The driving factors behind its growth include the rise in number of infertility cases, the demand for specialized facilities to conduct ART procedures, & the appeal of cost-effective, specialized, & customized treatments.
In addition, the hospitals are expected to witness significant growth in low- and middle-income countries, mainly in places where establishing dedicated fertility clinics presents infrastructure challenges. In such regions, multispecialty hospitals have emerged as the major and most accessible choice for infertility treatment in driving the growth of the market.
The Assisted Reproductive Technology Market Report is segmented on the basis of the following
By Type
- In-Virto Fertilization (IVF)
- Artificial Insemination
- Others
By End User
- Hospitals
- Fertility Clinics
- Others
Regional Analysis
Europe stands out as the region dominating the assisted reproductive technology (ART) market in
2023, contributing about 38.0% of the total revenue, which is linked to growth in infertility rates, a rise in awareness about fertility treatments, technological progress, & assistance from government programs. In addition, as per the European Society of Human Reproduction & Embryology, there are around
25 million individuals in the European Union grappling with infertility, the highest across the globe.
Moreover, North America is anticipated for significant growth in the ART market, mainly driven by positive patient outcomes from these treatments. In addition, technological advancements & increased research efforts in the field of ART are anticipated to further stimulate market expansion in the Asia Pacific region as well.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
In the market of Assisted Reproductive Technology (ART), competition experienced by the players is at a moderate level, marked by the involvement of key industry players, as they have established positions & contributions, shaping the landscape of ART services, driving innovation & quality in this specialized sector. This dynamic environment encourages advancements & choices for individuals seeking fertility solutions.
In February 2023, Bumrungrad International Hospital introduced its Fertility Center & IVF Clinic, providing complete reproductive services, which provides a complete range of care, from initial consultations to advanced Assisted Reproductive Technology (ART) procedures. It's a valuable resource for families looking for support on their journey to parenthood, offering a one-stop solution for all their reproductive needs.
Some of the prominent players in the global Assisted Reproductive Technology Market are:
- Ferring B.V.
- Fujifilm Irvine Scientific
- CooperSurgical Inc
- Vitrolife
- Microm Ltd
- Bloom IVF Centre
- Laboratoire CCD
- OvaScience Inc
- Esco Medical
- Cryolab Ltd
- Other Key Players
COVID-19 Pandemic & Recession: Impact on the Global Assisted Reproductive Technology Market:
The COVID-19 pandemic & the following economic recession had a diverse impact on the global Assisted Reproductive Technology (ART) market. While at the start disruptions like clinic closures & postponed treatments impacted the industry, there was a significant growth in demand as more individuals & couples turned to ART to fulfill their family planning goals during the lockdowns. Economic uncertainties led some to halt treatments, but overall, the ART market experienced resilience & adaptability, with ongoing growth driven by developing technology & evolving patient needs.
Report Details
| Report Characteristics |
| Market Size (2023) |
USD 28.7 Bn |
| Forecast Value (2032) |
USD 49.0 Bn |
| CAGR (2023-2032) |
6.1% |
| Historical Data |
2017 - 2022 |
| Forecast Data |
2023 - 2032 |
| Base Year |
2022 |
| Estimate Year |
2023 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Type (In-Virto Fertilization (IVF), Artificial
Insemination, and Others), By Others (Hospitals,
Fertility Clinics, and Others) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
Ferring B.V., Fujifilm Irvine Scientific, CooperSurgical
Inc, Vitrolife, Microm Ltd, Bloom IVF Centre,
Laboratoire CCD, OvaScience Inc, Esco Medical,
Cryolab Ltd, and Other Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Assisted Reproductive Technology Market is estimated to reach USD 28.7 billion in 2023,
which is further expected to reach USD 49.0 billion by 2032.
Europe dominates the Global Assisted Reproductive Technology Market with a share of 38.0% in 2023.
Some of the major key players in the Global Assisted Reproductive Technology Market are Ferring B.V.,
Microm Ltd, Vitrolife, and many others.
The market is growing at a CAGR of 6.1 percent over the forecasted period.